WGS Stock: Price, Earnings History and SEC Filings
GeneDx Holdings Corp. (WGS) last traded at $69.06, down 2.76% on the latest session and down 4.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.01 against an analyst estimate of $-0.19, a beat of 105.3%.
$69.06 -2.76%
1 month-4.48%
52-week high$170.87
52-week low$32.21
Volume886,154
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
WGS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $0.01 | $-0.19 | +105.26% |
| Mar 2026 | May 4, 2026 | $-0.28 | $-0.06 | -366.67% |
| Dec 2025 | Feb 23, 2026 | $0.14 | $0.11 | +27.27% |
| Sep 2025 | Oct 28, 2025 | $0.49 | $0.28 | +75.00% |
WGS beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for WGS
SEC filing data is not available right now. You can search for WGS on SEC EDGAR.
WGS news
- Our Pick Of The Best AI Healthcare Stocks In November 2026Nov 1, 2026 · finance.yahoo.com
- GeneDx Holdings And 2 Other Top Healthcare StocksOct 31, 2026 · finance.yahoo.com
- GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026Oct 23, 2026 · finance.yahoo.com
- How Long Can GeneDx Keep Burning Cash?Oct 21, 2026 · trefis.com
- Sector Update: Healthcare Stocks Gain Late AfternoonOct 20, 2026 · finance.yahoo.com
- GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease DiagnosisOct 20, 2026 · finance.yahoo.com
- GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026Oct 19, 2026 · finance.yahoo.com
About GeneDx Holdings Corp.
GeneDx Holdings Corp. (WGS) is a US-listed public company on Nasdaq.